Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier

Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone

(2015) Jean-Michel Lemée et al.   NEURO-ONCOLOGY

Spatial two-tissue compartment model for dynamic contrast-enhanced magnetic resonance imaging

(2014) Julia C. Sommer et al.   JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS

Stereotactic laser ablation of high-grade gliomas

(2014) Ammar H. Hawasli et al.   Neurosurgical Focus

The role of laser interstitial thermal therapy in enhancing progression-free survival of difficult-to-access high-grade gliomas: a multicenter study

(2014) Alireza M. Mohammadi et al.   Cancer Medicine

Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer

(2013) Jesper Kallehauge et al.   ACTA ONCOLOGICA

Magnetic Resonance Imaging-Guided Focused Laser Interstitial Thermal Therapy for Intracranial Lesions

(2013) Ammar H. Hawasli et al.   NEUROSURGERY

Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging

(2012) M. O. Leach et al.   EUROPEAN RADIOLOGY

Improving Efficiency of Adriamycin Crossing Blood Brain Barrier by Combination of Thermosensitive Liposomes and Hyperthermia

(2011) Wei Gong et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Bayesian adaptive randomization designs for targeted agent development

(2010) J. Jack Lee et al.   Clinical Trials

Blood-based diagnostics of traumatic brain injuries

(2010) Stefania Mondello et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

A comparison of tracer kinetic models forT1-weighted dynamic contrast-enhanced MRI: Application in carcinoma of the cervix

(2010) Stephanie B. Donaldson et al.   MAGNETIC RESONANCE IN MEDICINE

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY